Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.59 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.56 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.56 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.56 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.56 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.53 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.53 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.52 |
| ▸ | NT5E | P21589 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15453545 | 0.89 | LMNA (0.62) | P2RY12ADORA3LMNAALDH1A1GLA | |
| SCHEMBL13898193 | 0.85 | ADORA3 (0.62) | P2RY12ADORA3BMPR1BADORA1 | |
| SCHEMBL14394700 | 0.85 | P2RY12 (0.64) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL13902897 | 0.85 | P2RY12 (0.64) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL6597278 | 0.84 | P2RY12 (0.63) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL6597269 | 0.84 | P2RY12 (0.63) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL17824398 | 0.84 | P2RY12 (0.81) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL30666149 | 0.84 | P2RY12 (0.81) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL21953578 | 0.84 | LMNA (0.72) | ADORA3LMNAALDH1A1GLAPMP22 | |
| SCHEMBL6909853 | 0.84 | LMNA (0.72) | ADORA3LMNAALDH1A1GLAPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001517674-A | — | — | 2001-10-09 | — | — | JP | claimed |
| EP-1017703-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | Nanogen Recognomics GmbH (DE) | 2000-07-12 | — | — | EP | claimed |
| WO-1999015539-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-04-01 | — | — | WO | claimed |
| US-20040198966-A1 | Pentopyranosylnucleoside, its preparation and use | NANOGEN RECOGNOMICS GMBH | 2004-10-07 | — | — | US | disclosed |
| US-6608186-B1 | Of given formula; use for the production of a therapeutic, diagnostic and/or electronic component; use in the construction of supramolecular units | NANOGEN RECOGNOMICS GMBH (DE) | 2003-08-19 | — | — | US | disclosed |
| EP-1017703-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | Nanogen Recognomics GmbH (DE) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999015539-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198966-A1 | Pentopyranosylnucleoside, its preparation and use | FUT6, ST3GAL3, FUT5 | P2RY12 1423/4885P2RY2 1290/4885P2RY1 606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.